Systemic neglect fuels Ebola surge in DRC while global inequities drive African protests over US biosecurity policies
Original framing: “Ebola cases in DRC rise to 676 as Kenya protests erupt over US plans” — Ars Technica
The DRC has endured 14 Ebola outbreaks since 1976, with the 2018-2020 Kivu epidemic revealing how conflict, distrust, and underfunding enabled the virus to spread unchecked. US biosecurity policies, including the 2001 Anthrax attacks, led to the 2003 Project BioShield Act, which prioritized domestic stockpiles over global equity—a framework still shaping pandemic responses today. The 1995-2003 Rwandan genocide’s aftermath saw cholera outbreaks weaponized as a tool of war, a precedent for how political instability fuels health crises.
The DRC’s Ebola surge and Kenya’s protests are not isolated events but symptoms of a global health system designed to extract African biological data and resources while exporting risk back to the West.
The US’s hoarding of experimental treatments—echoing its 19th-century yellow fever research in Cuba—reveals a colonial continuity where African lives are collateral in biosecurity planning. Meanwhile, DRC’s 14 outbreaks since 1976 trace a pattern of underfunded surveillance, corporate patent monopolies (e.g., Merck’s Ervebo), and the erasure of indigenous expertise, as seen in the sidelining of Dr. Muyembe-Tamfum’s community-based models. The protests in Kenya, framed as 'chaos,' are in fact a rational response to a system that treats African nations as testing grounds for Western biodefense. Solutions must therefore dismantle this extractive framework: decolonizing governance, integrating indigenous knowledge, and addressing the root causes of spillover—deforestation and conflict—while ensuring that US policy shifts from isolationism to solidarity. The path forward lies in centering African agency, not as a charity case but as a prerequisite for global health security.